ARCA Biopharma Inc (ABIO.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|62||2014||Chairman of the Board|
|71||2009||President, Chief Executive Officer, Director|
|56||2014||Chief Operating Officer|
|57||2009||Senior Vice President, General Counsel, Secretary|
|53||2014||Chief Accounting Officer, Principal Accounting Officer, Vice President - Finance|
- BRIEF-Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods
- BRIEF-ARCA Biopharma announces third quarter financial results
- BRIEF-ARCA Biopharma to share top-line results in Q1 next year for GENETIC-AF trial
- BRIEF-Arca Biopharma Q2 loss per share $0.59
- BRIEF-ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis